MCRB Earnings — Seres Therapeutics, Inc. Post-ER Performance | BigEarnings
MCRB — Seres Therapeutics, Inc.
XNAS · Healthcare · Biotechnology
Price$7.32
Market Cap$70.9M
P/E—
52W Range$6.56 – $29.98
Next Earnings2026-08-05
About Seres Therapeutics, Inc.
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.
